ConductScience.org, home

Paper28056550

Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice.

Murad HA and 5 others. Exp Biol Med (Maywood), 2017. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice. Papers, record 28056550. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28056550

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice.
PubMed
Journal
Exp Biol Med (Maywood)
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2023-11-12
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Murad HAHussam A
2Habib HSHamed S
3Rafeeq MMMisbahuddin M
4Sulaiman MIMansour I
5Abdulrahman ASAmer S
6Khabaz MNMohamad Nidal

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminopyridinesMajor topic
Anti-Asthmatic AgentsMajor topic
AsthmaMajor topic
BenzamidesMajor topic
FluticasoneMajor topic
Formoterol FumarateMajor topic
Administration, Inhalation
Animals
Bronchoalveolar Lavage Fluid
Cyclopropanes
Disease Models, Animal
Drug Therapy, Combination
Female
Immunoglobulin E
Interleukin-4
Interleukin-5
Mice
Mice, Inbred BALB C
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117452546Inverse associations of Helicobacter pylori with asthma and allergy.Arch Intern Med2007https://conductscience.org/library/papers/17452546PubMed
215994257Is the neutrophil the key effector cell in severe asthma?Thorax2005https://conductscience.org/library/papers/15994257PubMed
326064325FOXP3(+)Treg/Th17 cell imbalance in lung tissues of mice with asthma.Int J Clin Exp Med2015https://conductscience.org/library/papers/26064325PubMed
421335522Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpoints.Am J Physiol Lung Cell Mol Physiol2011https://conductscience.org/library/papers/21335522PubMed
525310957Influence of roflumilast on airway reactivity and apoptosis in ovalbumin-sensitized Guinea pigs.Adv Exp Med Biol2015https://conductscience.org/library/papers/25310957PubMed
616393727Roflumilast inhibition of pulmonary leukotriene production and bronchoconstriction in ovalbumin-sensitized and -challenged Guinea pigs.J Asthma2005https://conductscience.org/library/papers/16393727PubMed
7245074182nd cross company respiratory symposium.J Inflamm (Lond)2012https://conductscience.org/library/papers/24507418PubMed
816126838Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation.J Pharmacol Exp Ther2005https://conductscience.org/library/papers/16126838PubMed
918236728When should a methacholine challenge be ordered for a patient with suspected asthma?Cleve Clin J Med2008https://conductscience.org/library/papers/18236728PubMed
1015860753Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.Am J Respir Crit Care Med2005https://conductscience.org/library/papers/15860753PubMed
1111259554Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.J Pharmacol Exp Ther2001https://conductscience.org/library/papers/11259554PubMed
1226296794Roflumilast for asthma: Efficacy findings in mechanism of action studies.Pulm Pharmacol Ther2015https://conductscience.org/library/papers/26296794PubMed
139309991Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.Am J Respir Crit Care Med1997https://conductscience.org/library/papers/9309991PubMed
1412944497
In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration.
J Pharmacol Exp Ther2003https://conductscience.org/library/papers/12944497PubMed
1520381629The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.Pulm Pharmacol Ther2010https://conductscience.org/library/papers/20381629PubMed
1614999617Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice.J Infect Dis2004https://conductscience.org/library/papers/14999617PubMed
1724106801Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.Am J Respir Cell Mol Biol2014https://conductscience.org/library/papers/24106801PubMed
1826343938Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?J Allergy Clin Immunol2015https://conductscience.org/library/papers/26343938PubMed
197512904Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.Drugs1994https://conductscience.org/library/papers/7512904PubMed
2018307529Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.Clin Exp Allergy2008https://conductscience.org/library/papers/18307529PubMed

See all 67 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
41711839Investigating the therapeutic potential of polymeric roflumilast nanosuspension in modulating asthma hallmarks using an in vivo ovalbumin model.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41711839PubMed
40534662Formoterol, the Most Effective Bronchodilator, Has No Anti-Inflammatory nor Metabolic Modulatory Effects in Severe Asthma Induced by Aspergillus fumigatus.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40534662PubMed
38133375Impact of a Polymer-Based Nanoparticle with Formoterol Drug as Nanocarrier System In Vitro and in an Experimental Asthmatic Model.Toxics2023https://conductscience.org/library/papers/38133375PubMed
36865049Investigation of apoptotic and autophagic effects of chronic roflumilast use on testicular tissue in rats by immunohistochemical and immunofluorescence methods.Iran J Basic Med Sci2023https://conductscience.org/library/papers/36865049PubMed
35658632Isoorientin ameliorates OVA-induced asthma in a murine model of asthma.Exp Biol Med (Maywood)2022https://conductscience.org/library/papers/35658632PubMed
35239781Rectal roflumilast improves trinitrobenzenesulfonic acid-induced chronic colitis in rats.Braz J Med Biol Res2022https://conductscience.org/library/papers/35239781PubMed
34434103Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases.Front Pharmacol2021https://conductscience.org/library/papers/34434103PubMed
33152094Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.Inflammopharmacology2021https://conductscience.org/library/papers/33152094PubMed
31106094A Case of Persistent Asthma Resistant to Available Treatment Options: Management Dilemma.Cureus2019https://conductscience.org/library/papers/31106094PubMed
30122895Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap.Drug Des Devel Ther2018https://conductscience.org/library/papers/30122895PubMed
29692733Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity.Front Pharmacol2018https://conductscience.org/library/papers/29692733PubMed
28589151Advanced Role of Neutrophils in Common Respiratory Diseases.J Immunol Res2017https://conductscience.org/library/papers/28589151PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28056550

GET https://conductscience.org/api/papers/v1/28056550/references?page=2